Avestar Capital, LLC Chembio Diagnostics, Inc. Transaction History

Avestar Capital, LLC

  • $951 Million
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Oct 29, 2020
SELL
$3.28 - $5.93 $38,736 - $70,033
-11,810 Closed
0 $0
Q2 2020

Jul 29, 2020
BUY
$3.18 - $15.54 $37,555 - $183,527
11,810 New
11,810 $38,000

About CHEMBIO DIAGNOSTICS, INC.

CEMI Quotes by TradingView
  • Ticker CEMI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 30,224,600
  • Description
  • Chembio Diagnostics, Inc., together with its subsidiaries, develops, manufactures, and commercializes point-of-care (POC) diagnostic tests that are used to detect or diagnose diseases. The company offers tests for COVID-19, HIV and Syphilis, and Zika virus. It also develops tests for malaria, dengue, chikungunya, Chagas, ebola, leishmaniasis, la...
More about CEMI
Track This Portfolio

Track Avestar Capital, LLC Portfolio

Follow Avestar Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Avestar Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Avestar Capital, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email